Daniel Utzschneider
@danielutzschneider.bsky.social
870 followers 280 following 15 posts
Lab Head @thedohertyinst.bsky.social | University of Melbourne CSL Centenary & NHMRC Fellow views my own https://www.doherty.edu.au/people/dr-daniel-utzschneider
Posts Media Videos Starter Packs
Reposted by Daniel Utzschneider
theviin.bsky.social
‼️Deadline approaching - Don't miss your chance to submit an oral abstract for 16th Annual Lorne Infection & Immunity Conference
📍Held 18-20 of February 2026 at the Mantra Lorne

📝 Career Development Awards also available

Apply at www.lorneinfectionimmunity.org

Deadline: Friday, 10th of October
Reposted by Daniel Utzschneider
timsparwasser.bsky.social
CSH Asia meeting on Immune Tolerance #CSHA
Reposted by Daniel Utzschneider
labwaggoner.bsky.social
TGFβ-driven, HOBIT-dependent tissue-residency programs promote tumor-infiltration of CD8 T cells, but disruption of TGFβ in these tumor-infiltrating cells enhances tumor control @natimmunol.nature.com www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Daniel Utzschneider
niclag.bsky.social
We're looking for an experienced lab manager to join our wonderful team investigating fundamental T cell biology 🤓
careers.pageuppeople.com/513/cw/en/jo...
Job Search
careers.pageuppeople.com
danielutzschneider.bsky.social
Great meeting to (be) lock(ed) in!
assocprofashhaque.bsky.social
Register TODAY: Melbourne Immunotherapy Network, 2-day Spring Symposium, Pentridge Prison, Coburg! 2-3 Sept '25.
Student Early Bird: $250, inc. conference dinner (No metal prison trays, I promise!)
Click below to register and submit your Abstract.
www.melbourneimmunotherapy.org/registration
Reposted by Daniel Utzschneider
benjhogan.bsky.social
We are recruiting a group leader in laboratory research at Peter Mac Cancer Centre in
Melbourne, Australia 🔬🦘💥

Work in a cutting edge research environment in a vibrant world city!

We value research excellence, creativity and diversity.

Join us!

careers.petermac.org/job/MELBOURN...
Group Leader
Group Leader
careers.petermac.org
Reposted by Daniel Utzschneider
magdalenaskipper.bsky.social
Inexplicably, US administration has launched an unprecedented assault on science, on research institutions & on vital international organizations & initiatives.

An assault on science anywhere is an assault on science everywhere; the global community must unite
🧪
www.nature.com/articles/d41...
Trump 2.0: an assault on science anywhere is an assault on science everywhere
US President Donald Trump is taking a wrecking ball to science and to international institutions. The global research community must take a stand against these attacks.
www.nature.com
Reposted by Daniel Utzschneider
petermaccc.bsky.social
In the media over the weekend, groundbreaking research from Peter Mac & The Doherty has uncovered a new way to enhance the immune system’s ability to fight cancer.

Work at Peter Mac led by @JohnstoneRicky and Dane Newman. More via @australian or here: www.petermac.org/about-us/new...
New immune system discovery could boost cancer treatment effectiveness - Peter MacCallum Cancer Centre
www.petermac.org
Reposted by Daniel Utzschneider
labwaggoner.bsky.social
ID3 defines stem-like T cells with high developmental potential that sustain T cell responses to chronic infection and cancer
www.science.org/doi/10.1126/...
@sciimmunology.bsky.social
danielutzschneider.bsky.social
Not sure I would be able to focus on the pub😂
danielutzschneider.bsky.social
How could this work?

IL-1 cytokines expand ID3+ stem-like T cells in vitro, boosting their ability to sustain T cell responses in chronic infections & cancer.

This could pave the way for next-gen T cell therapies with enhanced longevity & efficacy. Exciting possibilities ahead!
danielutzschneider.bsky.social
ID3+ T cells in acute settings show unique stem-like features, including the ability to sustain long-term immunity and exclusively form #Tpex cells in chronic infection & cancer.

Could this improve durability in T cell therapies? We think so! 🧬
danielutzschneider.bsky.social
#Tpex cells are key to sustaining T cell responses to chronic infection & cancer. Can we learn from #Tpex cells, and harness stem-like T cells in acute infection to improve chronic immune responses?

Yes! T cells identified in acute LCMV expressing ID3 and LY108 shape durable therapies
danielutzschneider.bsky.social
Really enjoyed writing this News & Views for @natimmunol.bsky.social on @tcellogic.bsky.social & teams recent @science.org paper - the first one 😉

Really beautiful work!!!

www.nature.com/articles/s41...
Reposted by Daniel Utzschneider
gabrielakhoury.bsky.social
🐳 Join us in sunny Lorne, Australia next month, 19-21 Feb, for the @theviin.bsky.social Infection and Immunity Conference. 🪼 Absolutely great line-up this year! In person (sea-side🐚) and virtual registration options available too. Don't miss out- www.lorneinfectionimmunity.org/registration
A photo of coastline called the great Ocean road in Victoria Australia. The water is blue and torquise. The waves crash on to rocky alcove and sandy beach. The conference is hosted at one of the local towns.